Skip to content
10-Q

Quarterly Report

AIMMUNE THERAPEUTICS, INC.

0001564590-19-041059

← back to feed
Filed
Nov 6, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Oct 31, 2019 63.3M sh
Capex Q3 2019 · Sep 30, 2019 $7.09M
Capex Q3 2019 · Sep 30, 2018 $8.3M
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$142.85M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$117.58M
Long Term Debt Q3 2019 · Sep 30, 2019 $39.78M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $76.84M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $107.51M
Stockholders Equity Q3 2019 · Sep 30, 2019 $152.69M
Stockholders Equity Q3 2019 · Jun 30, 2019 $204.97M
Stockholders Equity Q3 2019 · Mar 31, 2019 $256.3M
Stockholders Equity Q3 2019 · Dec 31, 2018 $298.95M
Stockholders Equity Q3 2019 · Sep 30, 2018 $247.16M
Stockholders Equity Q3 2019 · Jun 30, 2018 $287.84M
Stockholders Equity Q3 2019 · Mar 31, 2018 $329.09M
Stockholders Equity Q3 2019 · Dec 31, 2017 $177.81M
Current Liabilities Q3 2019 · Sep 30, 2019 $43.61M
Current Liabilities Q3 2019 · Dec 31, 2018 $38.01M
Total Liabilities Q3 2019 · Sep 30, 2019 $95.71M
Total Liabilities Q3 2019 · Dec 31, 2018 $40.61M
Current Assets Q3 2019 · Sep 30, 2019 $202.24M
Current Assets Q3 2019 · Dec 31, 2018 $312.62M
Total Assets Q3 2019 · Sep 30, 2019 $248.4M
Total Assets Q3 2019 · Dec 31, 2018 $339.56M
Rd Expense Q3 2019 · Sep 30, 2019 $30.56M
Rd Expense Q3 2019 · Sep 30, 2019 $93.86M
Rd Expense Q3 2019 · Sep 30, 2018 $31.69M
Rd Expense Q3 2019 · Sep 30, 2018 $100.39M
Net Income Q3 2019 · Sep 30, 2019 −$64.46M
Net Income Q3 2019 · Sep 30, 2019 −$181.6M
Net Income Q3 2019 · Jun 30, 2019 −$62.88M
Net Income Q3 2019 · Mar 31, 2019 −$54.27M
Net Income Q3 2019 · Sep 30, 2018 −$51.7M
Net Income Q3 2019 · Sep 30, 2018 −$153.75M
Net Income Q3 2019 · Jun 30, 2018 −$52.55M
Net Income Q3 2019 · Mar 31, 2018 −$49.5M
Operating Income Q3 2019 · Sep 30, 2019 −$64.6M
Operating Income Q3 2019 · Sep 30, 2019 −$182.82M
Operating Income Q3 2019 · Sep 30, 2018 −$52.98M
Operating Income Q3 2019 · Sep 30, 2018 −$156.91M